Skip to content
Trial Eligibility
Menu

UPenn Observational Research Repository on Neurodegenerative Disease

NCT04715399

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The aim of this study is to create a repository of both cross-sectional and longitudinal data, including cognitive, linguistic, imaging and biofluid biological specimens, for neurodegenerative disease research and treatment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Frontotemporal Degeneration(FTD)
  • Primary Progressive Aphasia(PPA)
  • Familial Frontotemporal Lobar Degeneration (fFTLD)
  • Amyotrophic Lateral Sclerosis(ALS)
  • Lewy Body Disease(LBD)
  • Progressive Supranuclear Palsy(PSP)
  • Corticobasal Syndrome(CBS)
  • Posterior Cortical Atrophy(PCA)
  • Alzheimer's Disease(AD)

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Pennsylvania
Last updated on ClinicalTrials.gov
January 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.